MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2016 International Congress

    Non-motor symptoms in PD candidates for DBS treatment

    M.G. dos Santos Ghilardi, R.C.R. Martinez, R.G. Cury, J.R. Aranha, M.J. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)

    Objective: To evaluate the prevalence and severity of non motor symptoms(NMS) in Parkinson's disease(PD) patients referred to a Deep Brain Stimulation(DBS) center. Background: NMS are…
  • 2016 International Congress

    Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease

    P.W. Ko, J.S. Park, K. Kang, H.W. Lee (Daegu, Korea)

    Objective: To evaluate (1) prevalence of peripheral neuropathy and (2) usefulness of known neuropathy scores in patients with Parkinson's disease (PD). Background: Peripheral neuropathy has…
  • 2016 International Congress

    Multidisciplinary Parkinson rehabilitation in the Netherlands: The effectiveness of points of Parkinson (POP)

    E.T. Steendam-Oldekamp, W.A.W.F. Rutgers, T. van Laar (Groningen, Netherlands)

    Objective: To analyze the effect of the POP rehab program for advanced PD patients on motor- and non-motor symptoms up to 2 years and determine…
  • 2016 International Congress

    Effect of botulinum toxin on the non-motor symptoms of dystonia

    E. Shakweh, R. Pearce, N. Pavese (London, United Kingdom)

    Objective: To assess the prevalence of non-motor symptoms (NMS) in patients with cervical dystonia and dystonic head tremor receiving standard botulinum toxin (BoNT) treatment and…
  • 2016 International Congress

    Pulmonary dysfunction in Parkinson’s disease: A feature of early disease?

    G. Baille, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

    Objective: To characterize the abnormalities in pulmonary function tests (PFT) in early-diagnosed PD patients and to assess their prognostic features 2 years after. Background: Pulmonary…
  • 2016 International Congress

    Neuropsychological assessment in the Luxembourg Parkinson’s cohort (HELP-PD)

    G. Hipp, P. Kolber, K. Roomp, M. Kerschenmeyer, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Schneider, R. Balling, N.J. Diederich, R. Krüger (Belvaux, Luxembourg)

    Objective: To report first results on the prevalence of cognitive non-motor symptoms in the Luxembourg Parkinson's cohort (HELP-PD). Background: HELP-PD aims to combine thorough assessment…
  • 2016 International Congress

    Exploring structural covariance networks of gray matter in Parkinson’s disease

    L.J. de Schipper, J. van der Grond, J. Marinus, J.J. van Hilten (Leiden, Netherlands)

    Objective: To investigate whether structural covariance networks (SCNs) can be used to detect disease-specific patterns of gray matter atrophy in Parkinson's disease (PD) and secondly,…
  • 2016 International Congress

    Outpatient management of Parkinson’s disease: A review of medication changes made to address both motor and non-motor symptoms

    B. Magennis, E.A. Donlon, E.M. Fallon, T. Lynch (Dublin, Ireland)

    Objective: To identify reasons for medication changes at outpatient movement disorder clinics and determine outcome of these changes at next clinic visit. Background: Parkinson's disease…
  • 2016 International Congress

    Non motor symptoms of Parkinson’s disease: Prevalence and impact on quality of life

    M. Chraa, K. Choulli, N. Kissani (Marrakech, Morocco)

    Objective: To highlight the frequency of non motor symptoms in patients with Parkinson's disease and to evaluate their impact on quality of life. Background: Parkinson's…
  • 2016 International Congress

    Speech evaluation in Parkinson’s disease using a transcribed version of the Frenchay dysarthria assessment

    M. Löhle, A. Zenker, R. Jäckel, C. Bosredon, R. Hoffmann, A. Storch (Rostock, Germany)

    Objective: To assess the usefulness and metric properties of a transcribed version of the Frenchay Dysarthria Assessment 2 (FDA-2) for speech evaluation in a cohort…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley